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Background
Allergy to pollen grass causes significant morbidity in
Poland. Allergic rhinitis is a common condition which,
at its most severe, can significantly impair quality of life
despite treatment with antihistamines and topical nasal
corticosteroids.
The aim of the study was to evaluate the efficiacy of
injection specific immunotherapy (SIT) mixture grass
pollen allergoide at 20 000 AUM/ml for seasonal allegic
rhinitis.
Methods
72 patients followed 12-month immunotherapy and
63 patients were observed without immunotherapy.
Clinical efficacy was based on symptom and medication
scores and the percentage of healthy days (days without
symptoms or medication). Severity of rhinitis scales,
visual analogue scale, evaluation of the treatment by
doctors and patients, immediate and delayed cutaneous
response and quality of life questionnaires were also
studied.
Results
The patients with immunotherapy showed decrease in
symptoms (p = 0.01), medication (p = 0.003) and both
(p =0.001), increase of healthy days (p=0.02) one year
after treatment. Rhinitis severity scales decreased after
immunotherapy. Both clinical evaluation by physicians
and patient’s self-evaluation showed efficacy in 81%
and 74% of the patients with SIT. None of these
changes were observed in group without SIT. Immedi-
ate cutaneous response was significantly reduced in
SIT patients compare to other patients, one year after
SIT.
Conclusions
A recombinant allergen vaccine can be a effective and
safe treatment to reduced symptoms of allergic rhinitis.
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